REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanothea S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Nanothea S.A. Profile Updated: September 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

nanothea is a company that specializes in the development of novel nanoparticles for cancer treatment and diagnosis using safe polymer nanocarriers. The company focuses on the research and development of biopolymer nanoparticles for accurate diagnosis and targeted treatment of cancer using radioisotopes. nanothea is dedicated to advancing cancer treatment through innovative nanotechnology.

Headquarters
Ul. Rakowiecka 36
Warsaw; Mazowieckie; Postal Code: 02-532

Contact Details: Purchase the Nanothea S.A. report to view the information.

Website: https://nanothea.com

Basic Information
Total Employees:
Purchase the Nanothea S.A. report to view the information.
Outstanding Shares:
Purchase the Nanothea S.A. report to view the information.
Registered Capital:
Purchase the Nanothea S.A. report to view the information.
Incorporation Date:
November 16, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
93.47%
Purchase this report to view the information.
6.53%
Company Performance
Financial values in the chart are available after Nanothea S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-95.47%
Operating profit (EBIT)
64.66%
EBITDA
65.91%
Net Profit (Loss) for the Period
58.45%
Total assets
-38.1%
Total equity
-31.3%
Return on Equity (ROE)
-51.61%
Quick Ratio
-0.41%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?